Skip to main content

Table 6 Data of liver function test and CBC in cirrhosis, HCC, control group

From: S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma

 Cirrhosis groupHCC groupControl groupOne-way ANOVA
Mean ± SDMin─maxMean ± SDMin─maxMean ± SDMin─maxFp value
S.GPT (U/L)55.91 ± 33.8415–13866.71 ± 43.1722–20115.35 ± 5.3710–2614.7630.001
S.GOT (U/L)84.71 ± 49.1020–244145.77 ± 161.8930–82118.85 ± 6.5412–349.3710.001
Albumin (g/dl)2.40 ± 0.611.4–3.82.24 ± 0.551.3–3.64.34 ± 0.313.8–4.8112.2560.001
Bilirubin Total (mg/dl)4.25 ± 3.890.46–20.75.92 ± 6.510.6–21.50.44 ± 0.170.2–0.88.5610.001
Bilirubin Direct (mg/dl)2.14 ± 2.090.1–10.73.35 ± 4.040.2–12.80.15 ± 0.050.1–0.28.0800.001
Hemoglobin (g/dl)10.23 ± 1.996–14.810.97 ± 1.428.3–14.612.14 ± 1.589.6–14.88.0460.001
RBCs (× 106/μL)3.59 ± 0.792.22–5.573.86 ± 0.583.2–5.794.45 ± 0.433.71–5.5511.3840.001
PLT (× 103/μL)111.71 ± 71.4324–342114.31 ± 67.5218–288267.75 ± 52.54174–35642.5450.001
WBC (× 103/μL)7.99 ± 3.413–158.89 ± 5.142.5–18.36.62 ± 1.294.2–92.1630.121
  1. This table shows that there was statistically significant increase in HCC in comparison to control and cirrhosis group with SGPT, SGOT, bilirubin total, and direct but there was statistically significant increase in control in comparison to HCC and cirrhosis group with albumin, HB, RBCs, and PLT